Literature DB >> 28674976

Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.

Anne E Harasta1, Lars M Ittner2,3,4.   

Abstract

Alzheimer's disease was first described in 1906 and since then tremendous efforts have been made to fully understand the disease pathology and to find a cure for this neurodegenerative disease. The diagnosis of Alzheimer's is still difficult, especially in early stages of the disease. Current treatment of Alzheimer's only ameliorates the symptoms but fails to provide a therapy. Over the last decades, animal models have been proven valuable in elucidating insights of the pathology. In vitro models using patient-derived cells are currently emerging and hold great promise in understanding the disease pathophysiology. Here, we introduce the neurobiology and genetic features of Alzheimer's and describe what we have learned from studies employing mouse models and patient-derived induced pluripotent stem cells.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β; Excitotoxicity; Induced pluripotent stem cells; Mouse models; Tau

Mesh:

Substances:

Year:  2017        PMID: 28674976     DOI: 10.1007/978-3-319-57193-5_1

Source DB:  PubMed          Journal:  Adv Neurobiol


  4 in total

1.  Neuroprotective Activities of Heparin, Heparinase III, and Hyaluronic Acid on the Aβ42-Treated Forebrain Spheroids Derived from Human Stem Cells.

Authors:  Julie Bejoy; Liqing Song; Zhe Wang; Qing-Xiang Sang; Yi Zhou; Yan Li
Journal:  ACS Biomater Sci Eng       Date:  2018-06-28

Review 2.  The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration.

Authors:  Yuanwei Yan; Julie Bejoy; Mark Marzano; Yan Li
Journal:  Cells       Date:  2019-03-14       Impact factor: 6.600

3.  Low and High Molecular Weight FGF-2 Have Differential Effects on Astrocyte Proliferation, but Are Both Protective Against Aβ-Induced Cytotoxicity.

Authors:  Xi Chen; Zhaojin Li; Yong Cheng; Elissavet Kardami; Y Peng Loh
Journal:  Front Mol Neurosci       Date:  2020-01-24       Impact factor: 5.639

Review 4.  Modeling and Targeting Alzheimer's Disease With Organoids.

Authors:  Angelos Papaspyropoulos; Magdalini Tsolaki; Nicolas Foroglou; Anastasia A Pantazaki
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.